[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632796":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":40,"centralContacts":47,"locations":53,"responsibleParty":69,"collaborators":31,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":31,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":31,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":99,"whyStopped":31,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"Assiut University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Topical minoxidil 5\u002F","ACTIVE_COMPARATOR","Patients will be taught how to apply topical minoxidil daily for three months",[13],"Drug: Minoxidil 5 %",{"label":15,"type":10,"description":16,"interventionNames":17},"PRP injection","Patients will receive three PRP injections one month apart each",[18],"Procedure: PRP injection",{"label":20,"type":21,"description":22,"interventionNames":23},"nanofat injection","EXPERIMENTAL","Patience well receive single nano fat injection",[24],"Procedure: Nanofat injection",[26,32,36],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DRUG","Minoxidil 5 %","Topical application of minoxidil 5%",[9],null,{"type":33,"name":15,"description":34,"armGroupLabels":35,"otherNames":31},"PROCEDURE","3 PRP injections one month apart",[15],{"type":33,"name":37,"description":38,"armGroupLabels":39,"otherNames":31},"Nanofat injection","Single nanofat injection",[20],[41,44],{"name":42,"affiliation":5,"role":43},"Hanan Ahmed Morsy, Professor Doctor","STUDY_CHAIR",{"name":45,"affiliation":5,"role":46},"Reham Maher Abdel Gaber, Doctor","STUDY_DIRECTOR",[48],{"name":49,"role":50,"phone":51,"phoneExt":31,"email":52},"Marina Aiad Aboelsaad, Bachelor of Medicine and Surge","CONTACT","+201282347199","marina.aiad16@gmail.com",[54],{"facility":5,"status":31,"city":55,"state":31,"zip":31,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"Asyut","Egypt","EG",{"type":59,"coordinates":60},"Point",[61,62],31.18368,27.18096,{"lat":62,"lon":61},[65],{"name":66,"role":50,"phone":67,"phoneExt":31,"email":68},"Vice president of graduate studies of Assiut University","+2088 22080150","vp_grad@aun.edu.eg",{"type":70,"investigatorFullName":71,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"PRINCIPAL_INVESTIGATOR","Marina Abdelmassieh Aiad Aboelsaad","Assistant lecturer","100632796","phase-4-the-effect-of-nanofat-injection-on-androgenetic-alopecia-100632796",false,"NCT07518342","The Effect of Nanofat Injection on Androgenetic Alopecia","Efficacy and Safety of Nanofat Injection vs Either PRP Injection or Topical Minoxidil 5% in Female and Male Pattern Androgenetic Alopecia","Inclusion criteria:\n\n* Adults (ages 18-50).\n* A clinical diagnosis of androgenetic alopecia confirmed by dermoscopy of both males and females.\n* No previous topical treatment used in the past 3 months.\n\nExclusion criteria:\n\n* Alopecia totalis and alopecia universalis.\n* Cicatricial alopecia.\n* Other causes of hair loss such as immunological disease.\n* Skin disease in the affected area.\n* Hypersensitivity or allergy to any of the treatment products used.\n* Patients using treatment (topical or systemic) for androgenetic alopecia in the last 3 months.\n* Pregnant and lactating females.\n* Patients with a history of hypertrophic scars or keloid formation.\n* Patients with active infection at the site of the lesion.\n* Skin disease in the affected area.\n* Hamilton norwood scale stage 6 and 7\n* Ludwig Scale stage 3","ALL","18 Years","50 Years",{"count":84,"type":85},60,"ESTIMATED","INTERVENTIONAL",[88],"PHASE4","Androgenetic alopecia is a condition that bothers a lot of people. The disadvantage of the FDA approved topical minoxidil is that the patient needs to be compliant every day for extended periods of time. This is the main reason why this study is being conducted, to see if a single nanofat injection is superior to applying either topical Minoxidil or PRP",[91,92],"Androgenetic Alopecia","Androgenetic Alopecia (AGA)",[91,94,95,96,20,97,98],"Alopecia","PRP","nanofat","Minoxidil","Topical minoxidil","NOT_YET_RECRUITING","2026-04-08",{"date":102,"type":103},"2026-04-13","ACTUAL",{"date":105,"type":85},"2026-04",{"date":107,"type":85},"2028-12",{"name":5,"class":6},1]